UPDATE - Gabelli Funds to Host 10th Annual Waste & Sustainability Symposium Thursday, April 4, 2024
GREENWICH, Conn., March 18, 2024 (GLOBE NEWSWIRE) -- Gabelli Funds, LLC, will host the 10th Annual Waste & Sustainability Symposium at the Harvard Club in New York City on Thursday, April 4, 2024. The symposium will draw companies with a focus on the themes of waste, water treatment, and the environment. Attendees will also have the opportunity to meet with management in a one-on-one setting.
Presenting Companies:
374Water Inc. (NASDAQ: SCWO) |
BioLargo, Inc. (OTC: BLGO) |
Casella Waste Systems, Inc. (NASDAQ: CWST) |
Greif, Inc. (NYSE: GEF) |
Loop Industries, Inc. (NASDAQ: LOOP) |
Perma-Fix Environmental Services, Inc. (NASDAQ: PESI) |
Quest Resource Holding Corporation (NASDAQ: QRHC) |
Ranpak Holdings Corp. (NYSE: PACK) |
Republic Services, Inc. (NYSE: RSG) |
Secure Energy Services Inc. (TSE: SES) |
The Planting Hope Company Inc. (TSXV: MYLK) |
Waste Connections, Inc. (NYSE: WCN) |
The Harvard Club, New York City, NY
Thursday, April 4, 2024
Registration Link: CLICK HERE
Gabelli Funds, LLC is a registered investment adviser with the Securities and Exchange Commission and is a wholly owned subsidiary of GAMCO Investors, Inc.
Contact:
Tony Bancroft
Portfolio Manager
(914) 921-5083
For further information please visit www.gabelli.com
-
Small-Cap and Value Stocks Are Undervalued
-
Why We Expect the Job Market’s Slowdown to Renew in 2024
-
5 Undervalued Stocks to Buy to Play a Little Defense
-
Markets Brief: AI Leaders Excel In Earnings Season So Far
-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
SiriusXM Earnings: Decent Results With Plan for Technology and Content Investment to Drive Growth
-
Coca-Cola Earnings: Solid Volume On Innovation and Digital Engagement
-
Is Berkshire Hathaway a Buy Before the Annual Meeting?
-
Investment Opportunities in the Drug Distribution Industry
-
Why the End of Quantitative Tightening Matters
-
Eli Lilly Earnings: Strong Weight-Loss Drug Sales Expand Margins
-
After Earnings, Is Meta Stock a Buy, a Sell, or Fairly Valued?
-
After Earnings, Is Boeing Stock a Buy, a Sell, or Fairly Valued?